MIF and type 1 diabetes mellitus: Higher plasma levels of TNF, MCP-1, and MIF (197, 199), and TLR-induced IL-1β and IL-6 production by monocytes is increased (200–202). IL-1β inhibition improves T1DM outcome (203–206)